Artivion, Inc. (AORT) Dividend History

Artivion, Inc. (AORT) specializes in the development, manufacturing, and distribution of medical devices and tissue products for cardiovascular and general surgical procedures. The company focuses on providing biologic tissue products used in heart valve replacements, vascular grafts, and other surgical interventions, emphasizing regenerative and preservation techniques.

1655 Roberts Boulevard N W, Kennesaw, GA, 30144
Phone: (770) 419-3355
Website: https://www.artivion.com
Dividend Yield: 0.39%
Dividend Frequency: Quarterly

Dividend History

Pay Date Amount Ex Dividend Date Record Date
December 18, 2015 $0.03 12/09/2015 12/11/2015
September 18, 2015 $0.03 09/09/2015 09/11/2015
June 19, 2015 $0.03 06/10/2015 06/12/2015
March 20, 2015 $0.03 03/11/2015 03/13/2015
December 19, 2014 $0.03 12/10/2014 12/12/2014
Show more

Dividends Summary

  • Artivion, Inc. has issued 14 dividend payments over the past 3 years
  • The most recent dividend was paid 3507 days ago, on December 18, 2015
  • The first recorded dividend was paid on September 21, 2012
  • The highest dividend payout was $0.03 per share
  • The average dividend over this 3 year span is $0.03 per share
  • Artivion, Inc. has increased its dividend payments by 20.00% since 2012

Company News

  • DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Artivion, Inc. Customers Whose Data May Have Been Compromised

    Artivion, Inc. experienced a data breach on November 20-21, 2024, where an unauthorized third party accessed network files potentially containing sensitive personal information like Social Security Numbers and driver's license details.

    GlobeNewswire Inc.
  • A Glimpse Into The Expert Outlook On Artivion Through 4 Analysts

    In the latest quarter, 4 analysts provided ratings for Artivion (NYSE:AORT), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 1 0 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $27.5, with a high estimate of $30.00 and a low estimate of $25.00. This current average reflects an increase of 10.0% from the previous average price target of $25.00. Deciphering Analyst Ratings: An In-Depth Analysis The perception of Artivion by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Frank Takkinen Lake Street Raises Buy $30.00 $28.00 Rick Wise Stifel Raises Buy $25.00 $22.00 Mike Matson Needham Raises Buy $30.00 $25.00 Mike Matson Needham Maintains Buy $25.00 $25.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments ...Full story available on Benzinga.com

    Benzinga
  • Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?

    AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

    Zacks Investment Research
    Featured Companies: AXGN
Page data last updated 07/25/2025 03:56:22 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included